COMMUNIQUÉS West-GlobeNewswire

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
15/01/2026
Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked No. 6 nationally for Urology by US News & World Report ® for 2025-26 [...]
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
15/01/2026
Among monotherapy expansion cohorts (n=21), ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, showing best-in-class potential for advanced cancer [...]
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
15/01/2026
Regulated manufacturing, hospital field trials, and regulatory filings now underway with Ebulent Medical in Shenzhen LAS VEGAS, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. ( OTCID: CBSC ) (“CBSC” [...]
R1 Prior Authorization, Now Powered by the Phare OS, Accelerates Care, Reduces Costs and Improves Accuracy
15/01/2026
Combines AI-Powered Technology with R1 Experts to Set a New Standard for Clearance and Denial Rates CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, [...]
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
15/01/2026
Vaccine was safe and well-tolerated and led to a significant increase in norovirus-specific antibodies in serum and breast milk Norovirus-specific IgA in infant stool correlated with breast milk IgA, suggesting passive [...]
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
15/01/2026
STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product, Jornay PM ( [...]
ViroMissile Appoints Michael G. Wood as Chief Business Officer
15/01/2026
SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- ViroMissile , Inc., a cancer immunotherapy company pioneering the IDOV™ (Intravenously Deliverable Oncolytic Virus) platform, today announced the appointment of Michael G. [...]
Extendicare Announces January 2026 Dividend of C$0.042 per Share
15/01/2026
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of [...]
HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting
15/01/2026
Company Shared Poster on Breakthrough Genetic Stratification Data from Positive Phase 2b OLIVE Trial Results for BH-200 MUNICH, Germany, Jan. 15, 2026 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC”), a clinical-stage [...]
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
15/01/2026
WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne [...]
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
15/01/2026
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. control There are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2 clinical trials to date [...]
Sienna Announces January Dividend
15/01/2026
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers
15/01/2026
GT Biopharma targets a portion of the estimated $362 billion global solid tumor market Preliminary, unaudited cash balance of approximately $7 million as of December 31, 2025 anticipated to extend cash runway into Q3 [...]
Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
15/01/2026
The Science, Clinical Promise, & Market Outlook MELBOURNE, Australia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on [...]
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
15/01/2026
TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, [...]
Adaptin Bio to Present at the 2026 Sequire Investor Summit in Puerto Rico
15/01/2026
CHARLOTTE, N.C., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio , Inc. (“Adaptin” or the “Company”), a biotechnology company focused on developing precision cancer therapies with targeted delivery to the brain and other [...]
Precipio Takes Major Steps Toward a Clean Balance Sheet
15/01/2026
Less than $80,000 of long-term debt, and 10,000 vendor warrants remain outstanding NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has made major [...]
Phonak Virto R Infinio recognized in the 2026 BIG Innovation Awards for redefining custom hearing
15/01/2026
STÄFA, Switzerland, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Phonak , a global leader in innovative hearing solutions, today announced that Virto R Infinio has been named an Innovative Product Winner in the 2026 BIG Innovation [...]
Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting
15/01/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 15 JANUARY 2026 at 16:30 EET Recommendation by the Orion Nomination Committee on the proposals to be [...]

Pages